285 related articles for article (PubMed ID: 22423663)
1. A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line.
Souissi I; Ladam P; Cognet JA; Le Coquil S; Varin-Blank N; Baran-Marszak F; Metelev V; Fagard R
Mol Cancer; 2012 Mar; 11():12. PubMed ID: 22423663
[TBL] [Abstract][Full Text] [Related]
2. Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotide--interference with interferon-gamma-STAT1-mediated killing.
Tadlaoui Hbibi A; Laguillier C; Souissi I; Lesage D; Le Coquil S; Cao A; Metelev V; Baran-Marszak F; Fagard R
FEBS J; 2009 May; 276(9):2505-15. PubMed ID: 19476491
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative mechanisms of a transcription factor decoy targeting signal transducer and activator of transcription (STAT) 3: the role of STAT1.
Lui VW; Boehm AL; Koppikar P; Leeman RJ; Johnson D; Ogagan M; Childs E; Freilino M; Grandis JR
Mol Pharmacol; 2007 May; 71(5):1435-43. PubMed ID: 17325127
[TBL] [Abstract][Full Text] [Related]
4. EGF-induced apoptosis in A431 cells is dependent on STAT1, but not on STAT3.
Grudinkin PS; Zenin VV; Kropotov AV; Dorosh VN; Nikolsky NN
Eur J Cell Biol; 2007 Oct; 86(10):591-603. PubMed ID: 17646016
[TBL] [Abstract][Full Text] [Related]
5. Application of decoy oligodeoxynucleotides strategy for inhibition of cell growth and reduction of metastatic properties in nonresistant and erlotinib-resistant SW480 cell line.
Asadi Z; Fathi M; Rismani E; Bigdelou Z; Johari B
Cell Biol Int; 2021 May; 45(5):1001-1014. PubMed ID: 33377576
[TBL] [Abstract][Full Text] [Related]
6. Absence of STAT1 disturbs the anticancer effect induced by STAT3 inhibition in head and neck carcinoma cell lines.
Shim SH; Sung MW; Park SW; Heo DS
Int J Mol Med; 2009 Jun; 23(6):805-10. PubMed ID: 19424608
[TBL] [Abstract][Full Text] [Related]
7. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.
Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G
Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672
[TBL] [Abstract][Full Text] [Related]
8. A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB.
Souissi I; Najjar I; Ah-Koon L; Schischmanoff PO; Lesage D; Le Coquil S; Roger C; Dusanter-Fourt I; Varin-Blank N; Cao A; Metelev V; Baran-Marszak F; Fagard R
BMC Cell Biol; 2011 Apr; 12():14. PubMed ID: 21486470
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors block IFNγ-induced STAT1 phosphorylation.
Ginter T; Bier C; Knauer SK; Sughra K; Hildebrand D; Münz T; Liebe T; Heller R; Henke A; Stauber RH; Reichardt W; Schmid JA; Kubatzky KF; Heinzel T; Krämer OH
Cell Signal; 2012 Jul; 24(7):1453-60. PubMed ID: 22425562
[TBL] [Abstract][Full Text] [Related]
10. STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma.
Wu C; Molavi O; Zhang H; Gupta N; Alshareef A; Bone KM; Gopal K; Wu F; Lewis JT; Douglas DN; Kneteman NM; Lai R
Blood; 2015 Jul; 126(3):336-45. PubMed ID: 25921060
[TBL] [Abstract][Full Text] [Related]
11. STAT3 inhibitors for cancer therapy: Have all roads been explored?
Fagard R; Metelev V; Souissi I; Baran-Marszak F
JAKSTAT; 2013 Jan; 2(1):e22882. PubMed ID: 24058788
[TBL] [Abstract][Full Text] [Related]
12. Tagging of genomic STAT3 and STAT1 with fluorescent proteins and insertion of a luciferase reporter in the cyclin D1 gene provides a modified A549 cell line to screen for selective STAT3 inhibitors.
Samsonov A; Zenser N; Zhang F; Zhang H; Fetter J; Malkov D
PLoS One; 2013; 8(7):e68391. PubMed ID: 23950841
[TBL] [Abstract][Full Text] [Related]
13. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
[TBL] [Abstract][Full Text] [Related]
14. STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6.
Galdiero M; Vitiello M; D'Isanto M; Raieta K; Galdiero E
Cytokine; 2006 Dec; 36(5-6):218-28. PubMed ID: 17258468
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase D3 regulates the expression of the immunosuppressive protein, PD‑L1, through STAT1/STAT3 signaling.
Cui B; Chen J; Luo M; Wang L; Chen H; Kang Y; Wang J; Zhou X; Feng Y; Zhang P
Int J Oncol; 2020 Apr; 56(4):909-920. PubMed ID: 32319563
[TBL] [Abstract][Full Text] [Related]
16. Human Cytomegalovirus Immediate-Early 1 Protein Rewires Upstream STAT3 to Downstream STAT1 Signaling Switching an IL6-Type to an IFNγ-Like Response.
Harwardt T; Lukas S; Zenger M; Reitberger T; Danzer D; Übner T; Munday DC; Nevels M; Paulus C
PLoS Pathog; 2016 Jul; 12(7):e1005748. PubMed ID: 27387064
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway.
Fang P; Hwa V; Rosenfeld RG
Exp Cell Res; 2006 May; 312(8):1229-39. PubMed ID: 16427044
[TBL] [Abstract][Full Text] [Related]
18. Arginine residues within the DNA binding domain of STAT3 promote intracellular shuttling and phosphorylation of STAT3.
Ginter T; Fahrer J; Kröhnert U; Fetz V; Garrone A; Stauber RH; Reichardt W; Müller-Newen G; Kosan C; Heinzel T; Krämer OH
Cell Signal; 2014 Aug; 26(8):1698-706. PubMed ID: 24721162
[TBL] [Abstract][Full Text] [Related]
19. In silico simulations of STAT1 and STAT3 inhibitors predict SH2 domain cross-binding specificity.
Szelag M; Sikorski K; Czerwoniec A; Szatkowska K; Wesoly J; Bluyssen HA
Eur J Pharmacol; 2013 Nov; 720(1-3):38-48. PubMed ID: 24211327
[TBL] [Abstract][Full Text] [Related]
20. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.
Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA
PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
